Paul Moayyedi

ORCID: 0000-0002-3616-9292
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Helicobacter pylori-related gastroenterology studies
  • Gastroesophageal reflux and treatments
  • Gastrointestinal motility and disorders
  • Eosinophilic Esophagitis
  • Microscopic Colitis
  • Inflammatory Bowel Disease
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Gut microbiota and health
  • Esophageal and GI Pathology
  • Colorectal Cancer Screening and Detection
  • Clostridium difficile and Clostridium perfringens research
  • Gastrointestinal disorders and treatments
  • Celiac Disease Research and Management
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Gallbladder and Bile Duct Disorders
  • Diet and metabolism studies
  • Pancreatic and Hepatic Oncology Research
  • Complementary and Alternative Medicine Studies
  • Congenital gastrointestinal and neural anomalies
  • Pediatric Hepatobiliary Diseases and Treatments
  • Veterinary medicine and infectious diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Inflammatory mediators and NSAID effects
  • Pancreatitis Pathology and Treatment

McMaster University
2016-2025

Population Health Research Institute
2016-2025

McMaster University Medical Centre
2011-2025

Hamilton Health Sciences
2015-2025

Digestive Health Research Institute
2014-2025

Cochrane
2022-2023

Impact
2022-2023

Canadian Association of Gastroenterology
2018-2021

Charles University
2020

University Hospital Kralovske Vinohrady
2020

Important progress has been made in the management of Helicobacter pylori infection and this fifth edition Maastricht Consensus Report, key aspects related to clinical role H. were re-evaluated 2015. In V/Florence Conference, 43 experts from 24 countries examined new data five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) Gastric Microbiota. The results individual workshops presented a final consensus voting that included...

10.1136/gutjnl-2016-312288 article EN Gut 2016-10-05

These guidelines provide a practical and evidence-based resource for the management of patients with Barrett9s oesophagus related early neoplasia. The Appraisal Guidelines Research Evaluation (AGREE II) instrument was followed to methodological strategy guideline development. A systematic review literature performed English language articles published up until December 2012 in order address controversial issues including definition, screening diagnosis, surveillance, pathological grading...

10.1136/gutjnl-2013-305372 article EN Gut 2013-10-28

IMPORTANCE Clostridium difficile infection (CDI) is a major burden in health care and community settings.CDI recurrence of particular concern because limited treatment options associated clinical control issues.Fecal microbiota transplantation (FMT) promising, but not readily available, intervention.OBJECTIVE To determine whether frozen-and-thawed (frozen, experimental) FMT noninferior to fresh (standard) terms efficacy among patients with recurrent or refractory CDI assess the safety both...

10.1001/jama.2015.18098 article EN JAMA 2016-01-12
Coming Soon ...